News | September 12, 2025
VedaBio to use Mammoth Biosciences’ CRISPR-based technology for diagnostic applications
CRISPR-based detection enables highly specific molecular recognition
CRISPR-based detection enables highly specific molecular recognition
Program provides access to Lilly-trained artificial intelligence to help accelerate breakthrough medicines
The company has received approval from DCGI to begin patient enrolment and dosing in the country
Edwards’ latest-generation balloon-expandable transcatheter heart valve incorporates a proprietary calcification-resistant tissue technology
RTX001 represents a groundbreaking advance in the treatment of end-stage liver disease, offering new hope for patients with limited options
Now integrates with Abbott’s instinct sensor and approved for type 2 diabetes
The three-day expo will feature an expansive exhibition showcasing MSMEs, startups, research institutions, future innovation pavilions, state showcases, and government initiatives
New targeted therapy offers hope for patients with unresectable or metastatic NSCLC harboring HER2 tyrosine kinase domain activating mutations
The hospital opens with 300 operational beds, including 100+ ICU beds and 5 advanced operating theatres
The new subcutaneous autoinjector for lecanemab offers a self-administered, at-home treatment option for early-stage Alzheimer's disease
Subscribe To Our Newsletter & Stay Updated
